There are roughly 225,000 new cases of lung cancer every year in the United States. Early diagnosis and treatment play a large role in improving outcomes. A recently developed nasal swab test could ...
(Reuters) - A new diagnostic test from Veracyte Inc could help many people avoid risky and costly invasive lung biopsies at a time when millions of American smokers are eligible for lung cancer ...
SAN ANTONIO, Texas--(BUSINESS WIRE)--A new economic study found that adding CyPath® Lung, bioAffinity Technologies’ noninvasive test for detection of early-stage lung cancer, to the standard of care ...
HAMPTON ROADS, Va. (WAVY) — Lung cancer is the leading cause of cancer deaths in America, and catching it early is vital. That’s exactly what a low-dose CT scan does, but only one-in-10 people at ...
At least two thirds of patients with chronic obstructive pulmonary disease (COPD) do not receive lung function testing that is recommended for the accurate diagnosis and effective management of the ...
SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- A groundbreaking study published in Translational Lung Cancer Research reveals the potential of LungCanSeek, a novel blood test that uses four protein markers ...
World Lung Day is an annual campaign observed on September 25th to raise awareness about lung health and promote better lung care around the world. As we age, our lungs, like many other organs, ...
Study by BAMC’s Michael Morris, M.D., and VA’s Sheila Habib, M.D., evaluated potential economic impact of CyPath® Lung for the early detection of lung cancer “Our study suggests the potential for a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback